-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 2,00 % | 4,08 % | -12,07 % | 133,14 % | 22,89 % | -0,97 % | -66,28 % |
| Celldex Therapeutics | -8,82 % | -9,49 % | 0,00 % | 62,09 % | 12,73 % | -23,93 % | 42,94 % |
| PDS Biotechnology Corp. | 6,26 % | 10,37 % | -8,43 % | -37,08 % | -20,90 % | -89,85 % | -86,20 % |
News
2 AI Stocks That Survived the March Sell-Off -- and Look Stronger Because of It
The March sell-off hit even the hottest areas of technology. However, not every tech stock was down for the month, and one pair of stocks in particular stood out as not only surviving the sell-off
AMD vs. Nvidia: The AI Supercycle Is Big Enough for Both. Here's the Better Buy.
The artificial intelligence (AI) boom is creating massive winners, but not every stock riding this wave will deliver the same type of returns for investors.
Nvidia (NASDAQ: NVDA) and Advanced Micro
Stock Market Today, April 2: Markets Muted on Mixed Iran War Reports
Oil and geopolitics remained firmly in focus before markets closed for Good Friday. The S&P 500 (SNPINDEX:^GSPC) rose 0.11% to 6,582.69, finishing the week up 1.63%. The Nasdaq Composite (NASDAQINDE


